PEDIAMYCIN 400 Drug Patent Profile
✉ Email this page to a colleague
When do Pediamycin 400 patents expire, and what generic alternatives are available?
Pediamycin 400 is a drug marketed by Arbor Pharms Llc and is included in one NDA.
The generic ingredient in PEDIAMYCIN 400 is erythromycin ethylsuccinate. There are one hundred and three drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the erythromycin ethylsuccinate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pediamycin 400
A generic version of PEDIAMYCIN 400 was approved as erythromycin ethylsuccinate by ARBOR PHARMS LLC on December 31st, 1969.
Summary for PEDIAMYCIN 400
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 54 |
Patent Applications: | 1,779 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PEDIAMYCIN 400 at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for PEDIAMYCIN 400
US Patents and Regulatory Information for PEDIAMYCIN 400
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Arbor Pharms Llc | PEDIAMYCIN 400 | erythromycin ethylsuccinate | SUSPENSION;ORAL | 062304-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |